Publications

Sex Hormone, Insulin, and Insulin-Like Growth Factor Signaling in Recurrence of High Stage Endometrial Cancer: Results from the Nrg Oncology/Gynecologic Oncology Group 210 Trial.

AuthID
P-00V-TBC

Author(s)

Huang, GS

Merritt, MA

Hutson, A

Einstein, M

Lankes, HA

Xue, X

Yu, H

Mannel, RS

O'Malley, DM

Mutch, DG

Disilvestro, P

Geller, MA

Guntupalli, SR

Birrer, MJ

Miller, DS

Gunter, MJ

Document Type

Article

Year published

2019

Published

in Journal of Clinical Oncology, ISSN: 0732-183X

Volume: 37, Issue: 15_suppl, Pages: 5509-5509

Indexing

Crossref^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1200/jco.2019.37.15_suppl.5509

Source Identifiers

ISSN: 0732-183X

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Sex Hormone, Insulin, and Insulin-Like Growth Factor Signaling in Recurrence of High Stage Endometrial Cancer: Results from the Nrg Oncology/Gynecologic Oncology Group 210 Trial.

Useful Links

Get Help

Federated Authentication (Click on the image)

Sex Hormone, Insulin, and Insulin-Like Growth Factor Signaling in Recurrence of High Stage Endometrial Cancer: Results from the Nrg Oncology/Gynecologic Oncology Group 210 Trial.

Useful Links

Get Help